Nadezhda Todorova

Dr. Nadezhda Todorova

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2015 in GigaScience
Verified
Journal Article
Open access
PDF file
AKAnna Kopf
Anna Kopf
MBMesude Bicak
Mesude Bicak
RKRenzo Kottmann
Renzo Kottmann
JSJulia Schnetzer
Julia Schnetzer
IKIvaylo Kostadinov
Ivaylo Kostadinov
FGFrank Oliver Glöckner
Frank Oliver Glöckner
Ocean Sampling Day was initiated by the EU-funded Micro B3 (Marine Microbial Biodiversity, Bioinformatics, Biotechnology) project to obtain a snapsho

20 November 2015 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
PDF file
Gabriella CarusoGabriella Caruso
Gabriella Caruso
RFRosabruna La Ferla
Rosabruna La Ferla
maurizio azzaromaurizio azzaro
maurizio azzaro
AZAnnamaria Zoppini
Annamaria Zoppini
GMGiovanna Marino
Giovanna Marino
RDRoberto Danovaro
Roberto Danovaro
Microbial assemblages for environmental quality assessment: Knowledge, gaps and usefulness in the European Marine Strategy Framework Directive. . ???aop.label???. doi: 10.3109/1040841X.2015.1087380

29 April 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
Anastassova NedaAnastassova Neda
Anastassova Neda
DADenitsa Aluani
Denitsa Aluani
NHNadya Hristova-Avakumova
Nadya Hristova-Avakumova
VTVirginia Tzankova
Virginia Tzankova
MKMagdalena Kondeva-Burdina
Magdalena Kondeva-Burdina
Denitsa Y. YanchevaDenitsa Y. Yancheva
Denitsa Y. Yancheva
Oxidative stress is a key contributing factor in the complex degenerating cascade in Parkinson’s disease. The inhibition of MAO-B affords higher dopamine bioavailability and stops ROS formation. The incorporation of hydroxy and methoxy groups in the arylhydrazone moiety of a new series of 1,3-disubstituted benzimidazole-2-thiones could increase the neuroprotective activity. In vitro safety evaluation on SH-SY5Y cells and rat brain synaptosomes showed a strong safety profile. Antioxidant and neuroprotective effects were evaluated in H2O2-induced oxidative stress on SH-SY5Y cells and in a model of 6-OHDA-induced neurotoxicity in rat brain synaptosomes, where the dihydroxy compounds 3h and 3i demonstrated the most robust neuroprotective and antioxidant activity, more pronounced than the reference melatonin and rasagiline. Statistically significant MAO-B inhibitory effects were exerted by some of the compounds where again the catecholic compound 3h was the most potent inhibitor similar to selegiline and rasagiline. The most potent antioxidant effect in the ferrous iron induced lipid peroxidation assay was observed for the three catechols—3h and 3j, 3q. The catecholic compound 3h showed scavenging capability against superoxide radicals and antioxidant effect in the iron/deoxyribose system. The study outlines a perspective multifunctional compound with the best safety profile, neuroprotective, antioxidant and MAO-B inhibiting properties.

Verified
Journal Article
Open access
PDF file
LLLeandar Litov
Leandar Litov
PPPeicho Stoev Petkov
Peicho Stoev Petkov
MRMiroslav Rangelov
Miroslav Rangelov
Nevena IlievaNevena Ilieva
Nevena Ilieva
Elena Boyanova LilkovaElena Boyanova Lilkova
Elena Boyanova Lilkova
GNGenoveva Nacheva
Genoveva Nacheva
Our objective is to reveal the molecular mechanism of the anti-inflammatory action of low-molecular-weight heparin (LMWH) based on its influence on the activity of two key cytokines, IFNγ and IL-6. The mechanism of heparin binding to IFNγ and IL-6 and the resulting inhibition of their activity were studied by means of extensive molecular-dynamics simulations. The effect of LMWH on IFNγ signalling inside stimulated WISH cells was investigated by measuring its antiproliferative activity and the translocation of phosphorylated STAT1 in the nucleus. We found that LMWH binds with high affinity to IFNγ and is able to fully inhibit the interaction with its cellular receptor. It also influences the biological activity of IL-6 by binding to either IL-6 or IL-6/IL-6Rα, thus preventing the formation of the IL-6/IL-6Rα/gp130 signalling complex. These findings shed light on the molecular mechanism of the anti-inflammatory action of LMWH and underpin its ability to influence favourably conditions characterised by overexpression of these two cytokines. Such conditions are not only associated with autoimmune diseases, but also with inflammatory processes, in particular with COVID-19. Our results put forward heparin as a promising means for the prevention and suppression of severe CRS and encourage further investigations on its applicability as an anti-inflammatory agent.

22 August 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
VAViolina T. Angelova
Violina T. Angelova
BGBorislav Ivanov Georgiev
Borislav Ivanov Georgiev
Tania PenchevaTania Pencheva
Tania Pencheva
IPIlza Pajeva
Ilza Pajeva
MRMiroslav Rangelov
Miroslav Rangelov
VTVirginia Tzankova
Virginia Tzankova
Alzheimer’s disease (AD) is considered a complex neurodegenerative condition which warrants the development of multitargeted drugs to tackle the key pathogenetic mechanisms of the disease. In this study, two novel series of melatonin- and donepezil-based hybrid molecules with hydrazone (3a–r) or sulfonyl hydrazone (5a–l) fragments were designed, synthesized, and evaluated as multifunctional ligands against AD-related neurodegenerative mechanisms. Two lead compounds (3c and 3d) exhibited a well-balanced multifunctional profile, demonstrating intriguing acetylcholinesterase (AChE) inhibition, promising antioxidant activity assessed by DPPH, ABTS, and FRAP methods, as well as the inhibition of lipid peroxidation in the linoleic acid system. Compound 3n, possessing two indole scaffolds, showed the highest activity against butyrylcholinesterase (BChE) and a high selectivity index (SI = 47.34), as well as a pronounced protective effect in H2O2-induced oxidative stress in SH-SY5Y cells. Moreover, compounds 3c, 3d, and 3n showed low neurotoxicity against malignant neuroblastoma cell lines of human (SH-SY5Y) and murine (Neuro-2a) origin, as well as normal murine fibroblast cells (CCL-1) that indicate the in vitro biocompatibility of the experimental compounds. Furthermore, compounds 3c, 3d, and 3n were capable of penetrating the blood–brain barrier (BBB) in the experimental PAMPA-BBB study. The molecular docking showed that compound 3c could act as a ligand to both MT1 and MT2 receptors, as well as to AchE and BchE enzymes. Taken together, those results outline compounds 3c, 3d, and 3n as promising prototypes in the search of innovative compounds for the treatment of AD-associated neurodegeneration with oxidative stress. This study demonstrates that hydrazone derivatives with melatonin and donepezil are appropriate for further development of new AChE/BChE inhibitory agents.

1 September 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
VAViolina T. Angelova
Violina T. Angelova
MRMiroslav Rangelov
Miroslav Rangelov
Nadezhda TodorovaNadezhda Todorova
Nadezhda Todorova
MDMiroslav Dangalov
Miroslav Dangalov
PAPavlina Andreeva-Gateva
Pavlina Andreeva-Gateva
Jana Dimitrova TchekalarovaJana Dimitrova Tchekalarova
Jana Dimitrova Tchekalarova